232 related articles for article (PubMed ID: 36119834)
1. A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer.
Feng D; Shi X; You J; Xiong Q; Zhu W; Wei Q; Yang L
Am J Cancer Res; 2022; 12(8):3811-3828. PubMed ID: 36119834
[TBL] [Abstract][Full Text] [Related]
2. A Ferroptosis-Related Gene Prognostic Index Associated With Biochemical Recurrence and Radiation Resistance for Patients With Prostate Cancer Undergoing Radical Radiotherapy.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Wei W; Yang L
Front Cell Dev Biol; 2022; 10():803766. PubMed ID: 35223835
[No Abstract] [Full Text] [Related]
3. A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer.
Feng D; Li D; Shi X; Xiong Q; Zhang F; Wei Q; Yang L
J Transl Med; 2022 Jun; 20(1):252. PubMed ID: 35658892
[TBL] [Abstract][Full Text] [Related]
4. A Gene Prognostic Index Associated With Epithelial-Mesenchymal Transition Predicting Biochemical Recurrence and Tumor Chemoresistance for Prostate Cancer.
Feng D; Shi X; Xiong Q; Zhang F; Li D; Yang L
Front Oncol; 2021; 11():805571. PubMed ID: 35096608
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Aldehyde Dehydrogenase 2 Represents a Potential Biomarker of Biochemical Recurrence in Prostate Cancer Patients.
Feng D; Zhu W; You J; Shi X; Han P; Wei W; Wei Q; Yang L
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144737
[TBL] [Abstract][Full Text] [Related]
6. An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer.
Zhu WZ; Feng DC; Xiong Q; Shi X; Zhang FC; Wei Q; Yang L
Asian J Androl; 2023; 25(2):208-216. PubMed ID: 36412461
[TBL] [Abstract][Full Text] [Related]
7. Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy.
Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L
Front Immunol; 2022; 13():839362. PubMed ID: 35280985
[TBL] [Abstract][Full Text] [Related]
8. Identification of senescence-related molecular subtypes and key genes for prostate cancer.
Feng DC; Zhu WZ; Shi X; Xiong Q; You J; Wei Q; Yang L
Asian J Androl; 2023; 25(2):223-229. PubMed ID: 36124532
[TBL] [Abstract][Full Text] [Related]
9. Developing an immune-related gene prognostic index associated with progression and providing new insights into the tumor immune microenvironment of prostate cancer.
Feng D; Zhang F; Li D; Shi X; Xiong Q; Wei Q; Yang L
Immunology; 2022 Jun; 166(2):197-209. PubMed ID: 35271752
[TBL] [Abstract][Full Text] [Related]
10. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy.
Feng D; Shi X; Zhang F; Xiong Q; Wei Q; Yang L
Front Oncol; 2022; 12():858479. PubMed ID: 35463369
[TBL] [Abstract][Full Text] [Related]
12. Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy.
Feng D; Wang J; Li D; Wu R; Wei W; Zhang C
Discov Oncol; 2023 Aug; 14(1):155. PubMed ID: 37624511
[TBL] [Abstract][Full Text] [Related]
13. Identification of senescence-related lncRNA prognostic index correlating with prognosis and radiosensitivity in prostate cancer patients.
Feng D; Li L; Shi X; Zhu W; Wang J; Wu R; Li D; Wei W; Han P
Aging (Albany NY); 2023 Sep; 15(18):9358-9376. PubMed ID: 37742230
[TBL] [Abstract][Full Text] [Related]
14. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
15. Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
Luan J; Zhang Q; Song L; Wang Y; Ji C; Cong R; Zheng Q; Xu Z; Xia J; Song N
Transl Androl Urol; 2021 Mar; 10(3):1018-1029. PubMed ID: 33850736
[TBL] [Abstract][Full Text] [Related]
16. LTBP2 inhibits prostate cancer progression and metastasis via the PI3K/AKT signaling pathway.
Zhang X; Tian C; Cheng J; Mao W; Li M; Chen M
Exp Ther Med; 2022 Sep; 24(3):563. PubMed ID: 36034756
[TBL] [Abstract][Full Text] [Related]
17. Prolyl 4-hydroxylase subunit beta (P4HB) could serve as a prognostic and radiosensitivity biomarker for prostate cancer patients.
Feng D; Li L; Li D; Wu R; Zhu W; Wang J; Ye L; Han P
Eur J Med Res; 2023 Jul; 28(1):245. PubMed ID: 37480146
[TBL] [Abstract][Full Text] [Related]
18. A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7.
Wu X; Lv D; Lei M; Cai C; Zhao Z; Eftekhar M; Gu D; Liu Y
Oncol Lett; 2020 Sep; 20(3):2906-2918. PubMed ID: 32782607
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Biological Significance of DNA Methylation-Driven Differentially Expressed Genes in Biochemical Recurrence After Radical Prostatectomy.
Luo C; He S; Zhang H; He S; Qi H; Wei A
Front Genet; 2022; 13():727307. PubMed ID: 35186021
[No Abstract] [Full Text] [Related]
20. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
Zhang Q; Zhao K; Song L; Ji C; Cong R; Luan J; Zhou X; Xia J; Song N
Front Genet; 2020; 11():586376. PubMed ID: 33329725
[No Abstract] [Full Text] [Related]
[Next] [New Search]